Skip Header
Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Hiscox reports record profits, announces $175m share buyback

(Sharecast News) - Insurer Hiscox reported record full-year profits on Thursday as it hailed "strong returns" from each business segment and announced a $175m share buyback. In the year to the end of December 2024, pre-tax profit rose 9.5% on the previous year to $685.4m.

Net insurance contract written premiums ticked up to $3.7bn from $3.6bn and insurance contract written premiums grew 3.7% to $4.8bn, driven by Retail premium growth of $147.3m.

The group combined ratio improved a touch to 84.7% from 85.5% a year earlier. The combined ratio is a measure of an insurer's profitability. A ratio below 100% indicates that the company is making an underwriting profit, while a ratio above means it is paying out more money in claims than it is receiving from premiums.

Hiscox also said it expects a net loss of around $170m from the California wildfires, and an industry loss of $40bn. It said this is event is largely a reinsurance loss with $150m expected to be recognised in Hiscox Re & ILS, and $10m in each of Hiscox London Market and Hiscox Retail.

Chief executive Aki Hussain said: "The group has delivered another set of excellent results and a second consecutive year of record profits. Our Retail business continues to build broad-based growth and earnings momentum, and our big-ticket portfolio has again delivered an outstanding performance, leading to a strong return on equity in an active loss year.

"This earnings momentum underpins substantial capital generation, creating the flexibility to pursue multiple growth opportunities and return 10% of equity to shareholders through a combination of a 20% step-up in the final dividend per share and a $175 million share buyback. This demonstrates both the power of - and confidence in - the outlook for our diversified business."

Share this article

Related Sharecast Articles

GSK gets preliminary nod for two respiratory drugs in Europe
(Sharecast News) - GSK said on Friday afternoon that two of its respiratory medicines had received positive opinions from the European Medicines Agency's Committee for Medicinal Products for Human Use, bringing the company closer to potential approvals across severe asthma, chronic rhinosinusitis with nasal polyps and chronic obstructive pulmonary disease.
Shore Capital hails improved US biotech funding environment for hVIVO
(Sharecast News) - Shares in AIM-listed hVIVO were continuing their recent surge on the back of encouraging signs from the US biotech market, which broker Shore Capital said has created a "much more favourable environment" for the company.
Weir to buy remaining 50% stake in Chile JV ESEL for £56m
(Sharecast News) - Weir said on Friday that it has agreed to buy the remaining 50% share of its Chile-based joint venture ESEL for a sterling equivalent purchase price of £56m.
Jefferies downgrades Whitbread, upgrades IHG
(Sharecast News) - Jefferies downgraded Whitbread to 'hold' from 'buy' on Friday as it applied the reverse upgrade to InterContinental Hotels.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Award-winning online share dealing

Search, compare and select from thousands of shares.

Expert insights into investing your money

Our team of experts explore the world of share dealing.